SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-073005
Filing Date
2023-06-21
Accepted
2023-06-20 17:55:01
Documents
12
Period of Report
2023-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319255d1_8k.htm   iXBRL 8-K 40894
  Complete submission text file 0001104659-23-073005.txt   215958

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sls-20230620.xsd EX-101.SCH 3254
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20230620_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20230620_pre.xml EX-101.PRE 22378
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2319255d1_8k_htm.xml XML 3608
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 231026717
SIC: 2834 Pharmaceutical Preparations